Pf-05212384 drug page Clinical trials

Trials with Pf-05212384

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

1Trials
0Recruiting
4Countries
19Planned patients

Showing 1–1 of 1

A Study Of PF-05212384 Plus Irinotecan Vs Cetuximab Plus Irinotecan In Patients With KRAS And NRAS Wild Type Metastatic Colorectal Cancer
Finished Phase 2 19 patients NCT01925274

This study will investigate whether the combination of PF-05212384 plus Irinotecan improves progression free survival in patients with KRAS and NRAS wild type metastatic colorectal cancer when compared with the combination of cetuximab plu…

United States, Japan, South Korea, Spain Nov 2013 – Apr 2016 Interventional
Combined with: CetuximabIrinotecan